Boston Scientific Corporation vs INTERVASCULAR, SAS: FDA Enforcement Comparison

Boston Scientific Corporation has been the subject of 294 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for INTERVASCULAR, SAS.

Boston Scientific Corporation: 0 warning letters, 294 recalls, 0 approval records, 0 Form 483s.

INTERVASCULAR, SAS: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

Side by side

Boston Scientific Corporation — Warning letters0

INTERVASCULAR, SAS — Warning letters0

Boston Scientific Corporation — Recalls294

INTERVASCULAR, SAS — Recalls1

Boston Scientific Corporation — Approval records0

INTERVASCULAR, SAS — Approval records0

Boston Scientific Corporation — Form 483s0

INTERVASCULAR, SAS — Form 483s0

Timeline

Boston Scientific Corporation

Most recent FDA action: September 30, 2026

Full history →

INTERVASCULAR, SAS

Most recent FDA action: September 30, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Boston Scientific Corporation vs INTERVASCULAR, SAS: FDA Enforcement Comparison." Argus HQ, accessed October 12, 2026. https://argushq.ai/compare/boston-scientific-corporation-vs-intervascular-sas

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗